DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $9,000 | -96.6% | 85 | -96.9% | 0.00% | -100.0% |
| Q1 2016 | $264,000 | +1.9% | 2,785 | 0.0% | 0.01% | +22.2% |
| Q4 2015 | $259,000 | -29.8% | 2,785 | -35.6% | 0.01% | -30.8% |
| Q3 2015 | $369,000 | -94.1% | 4,325 | -94.1% | 0.01% | -93.5% |
| Q2 2015 | $6,285,000 | -12.0% | 73,432 | -12.7% | 0.20% | -11.6% |
| Q1 2015 | $7,138,000 | -23.7% | 84,077 | -23.0% | 0.22% | -29.2% |
| Q4 2014 | $9,355,000 | +25.6% | 109,151 | +11.4% | 0.32% | +27.2% |
| Q3 2014 | $7,446,000 | -26.5% | 97,996 | -23.9% | 0.25% | -25.8% |
| Q2 2014 | $10,135,000 | +1.2% | 128,732 | -3.6% | 0.34% | -0.6% |
| Q1 2014 | $10,018,000 | +0.5% | 133,572 | +3.4% | 0.34% | -2.6% |
| Q4 2013 | $9,969,000 | -1.6% | 129,135 | -11.6% | 0.35% | -8.4% |
| Q3 2013 | $10,126,000 | +22.3% | 146,069 | +11.7% | 0.38% | +8.6% |
| Q2 2013 | $8,278,000 | – | 130,779 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |